FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | |||
|
||||
Grand Magnate
|
__________________
Knowledge is power. |
|||
![]() |
![]() |
"Thanks for this!" says: |
![]() |
#2 | |||
|
||||
Magnate
|
I read the BBC News Report about this. It does look interesting.
Dave.
__________________
You and I are yesterday's answers, The earth of the past come to flesh, Eroded by Time's rivers To the shapes we now possess. The Sage - Emerson, Lake & Palmer. |
|||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Grand Magnate
|
Dave, it does indeed look interesting.
One good thing is that bexarotene has FDA approval as a cancer chemotherapeutic which means that the basic (Phase 1 clinical trials) checking will have been done. So, with luck and more work (if it checks out) it might be possible to introduce it as an AD treatment fairly soon.
__________________
Knowledge is power. |
|||
![]() |
![]() |
"Thanks for this!" says: | EnglishDave (02-16-2016) |
Reply |
Thread Tools | |
Display Modes | |
|
|
![]() |
||||
Thread | Forum | |||
...a promising therapeutic approach for Parkinson's disease | Parkinson's Disease | |||
New approach promising against multiple sclerosis | Multiple Sclerosis |